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Introduction {#sec1}
============

Cell transplantation therapies using embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC)-derived retinal tissue (ESC/iPSC retina) or cells have emerged as therapeutic options for retinal degeneration following recent breakthroughs. A number of groups have shown that transplantation of postnatal or ESC/iPSC-derived photoreceptor precursor cells can integrate and restore visual function after transplantation into an adult mouse model of retinal degeneration that retains the photoreceptor layer (outer nuclear layer \[ONL\]) ([@bib21], [@bib30], [@bib41]), although the mechanism by which photoreceptor function is restored has recently been suggested as rescue of surviving host cells by material transfer from donor cells, rather than by direct cell integration ([@bib31], [@bib35], [@bib40]). Another breakthrough was the introduction of a protocol for self-organizing three-dimensional retinal differentiation from mouse ESCs (mESCs) ([@bib7]), which was successfully adapted to human ESCs (hESCs) ([@bib28]) and human iPSCs (hiPSCs) ([@bib48]). Since then, in addition to the increasing number of reports that mouse or hESC/iPSC-derived photoreceptor precursors could integrate into, or transfer materials to, host ONL ([@bib6], [@bib12], [@bib14], [@bib36], [@bib49]), we and others have reported that transplanted ESC/iPSC retinal sheets or photoreceptors can make *de novo* synaptic connections and restore some visual functions in end-stage retinal degeneration models with no ONL structure ([@bib2], [@bib3], [@bib26], [@bib39]).

Human ESCs take as long as 200 days to differentiate into fully mature retina, which was presented by immunohistology in monkeys and also by the presence of outer segments in nude rats following the transplantation ([@bib39]). However, hESC retinal cells do not always mature properly in xenograft rodent models, especially when there is damage due to the surgical procedure ([@bib14]). Although some researchers reported successful transplantation of human cells in rodent hosts with immunosuppression, graft survival was usually monitored for a relatively short period such as within several weeks ([@bib3]). Even with immunosuppression, mild rejection can be observed that may inhibit synaptic formation ([@bib22]). For these reasons, SD-Foxn1 Tg(S334ter)3LavRrrc rats were developed ([@bib37], [@bib38]), and we reported that transplanted hESC retina developed an organized ONL with potential synaptic connections to host bipolar cells ([@bib39]). Although the SD-Foxn1 Tg(S334ter)3LavRrrc rat is a good model for proof-of-concept studies using human cells, mouse models for which abundant phenotypic studies and gene expression databases are available would be more desirable. Moreover, mice are more accessible to genetic manipulations such as introduction of reporter genes. Recently, [@bib49] reported up to 9 months' survival of transplanted hESC-derived photoreceptors with some function in IL2Rg-deficient CRX-mutant mice, but the possibility of material transfer cannot be excluded due to the remaining host photoreceptors. Thus, immunodeficient end-stage retinal degeneration mouse models with absent ONL structure would be useful for preclinical studies featuring transplantation of hESC/iPSC-derived cells and tissues.

In 2002, [@bib15] established an appropriate animal recipient model for xenotransplantation: non-obese diabetes (NOD)/Shi-SCID, IL2Rg^null^ (NOG) mice. Characteristics of NOG mice are as follows: (1) lack of T, B, and natural killer (NK) cells; (2) reduced function of macrophage and dendritic cells; and (3) lack of complement activity. This NOG mouse model has been used to study the human lymphoid system by transplanting human cord blood-derived hematopoietic stem cells, and is very useful for testing the tumorigenicity of human cells ([@bib18], [@bib25], [@bib42]).

In this report, we established mouse models suitable for human retinal cell transplantation by introducing phosphodiesterase 6B (*Pde6b*) mutant allele from retinal degeneration (rd) mouse models into NOG background. *Pde6b*^*rd1/rd1*^ (*rd1*) and *Pde6b*^*rd10/rd10*^ (*rd10*) mice are well-studied and frequently used animal models of retinal degeneration with different degeneration speeds. The missense point mutation in *Pde6b* carried in these mice is also found as a causal gene of human autosomal recessive retinitis pigmentosa (RP). *Rd1* presents a phenotype of progressive retinal degeneration similar to that seen in C3H and *Pde6b*^*rd1*-*2J/rd1*-*2J*^ (*rd1-2J*) mice, with the onset of photoreceptor degeneration at around postnatal day 16 (P16), and loss of photoreceptors within the first 3--4 postnatal weeks ([@bib4], [@bib19]). *Rd10* exhibits a slightly slower photoreceptor degeneration starting between P16 and P20, and most of the photoreceptors disappear by P60 ([@bib33]).

We first characterized the degeneration phenotype in these rd mice with NOG background because immune responses have been suggested to accompany or modulate the pathogenesis of neurodegenerative diseases ([@bib5], [@bib11], [@bib16], [@bib29], [@bib43], [@bib44], [@bib45], [@bib46], [@bib47]). *Rd1* mice in the background of SCID, or in combination with RAG-1 knockout (no functional B and T cells) or a C1qα knockout (no functional classical complement activation pathway) ([@bib34]) or NOD (no functional B and T cells and low activity of NK cells) ([@bib27]) showed no difference in the degeneration speed, while *rd10* mice with *Ccr2* knockout ([@bib13]) and *Cx3cr1* knockout ([@bib32]) exhibited slower degeneration. We next transplanted hESC retinal sheets, to confirm the long-term survival and functional integration of graft cells in NOG-*rd1-2J* mice by immunohistochemistry and electrophysiology recording.

Results {#sec2}
=======

Development of NOG-*rd1-2J* and NOG-*rd10* Mice, Retinal Degeneration Models with Severe Immunodeficiency {#sec2.1}
---------------------------------------------------------------------------------------------------------

We used marker-assisted breeding to develop immunodeficient retinal degeneration mouse models for transplantation of hESC retina (summarized in [Figure 1](#fig1){ref-type="fig"}A; details in [Experimental Procedures](#sec4){ref-type="sec"}). Using this marker-assisted breeding, we were able to obtain two types of NOG-rd transgenic mice within a relatively short period of 420 days.Figure 1Breeding of NOG-*rd1-2J* Mice and NOG-*rd10* Mice, Immunodeficient and Retinal Degeneration Mouse Models(A) Schema of the marker-assisted screening methods. The first generation (N1) was obtained by *in vitro* fertilization (IVF) of male rd mice and female NOD/Shi-scid, IL2Rg^null^ (NOG) mice. Next, female N1 mice were mated with male non-obese diabetes (NOD) mice until we obtained the N5. Marker-assisted selection with the microsatellite markers was then performed to select the mice closest to NOD strain. Finally, the selected male mice and NOG females were used for IVF to obtain the NOG line.(B--G) Degeneration of photoreceptor cells were confirmed in NOG-*rd1-2J* mice and NOG-*rd10* mice (NOG-rd mice). OCT images of NOG-*Pde6b*^*rd1*-*2J/*+^ and NOG-*Pde6b*^*rd1*-*2J/rd1*-*2J*^ mice (B), NOG-*Pde6b*^*rd10/*+^ and NOG-*Pde6b*^*rd10/rd10*^ mice (C) at postnatal week 8. No outer nuclear layer was observed in NOG-*Pde6b*^*rd1*-*2J/rd1*-*2J*^ and NOG-*Pde6b*^*rd10/rd10*^ mice. ERG analysis of NOG-*Pde6b*^*rd1*-*2J/*+^ and NOG-*Pde6b*^*rd1*-*2J/rd1*-*2J*^ mice (D), NOG-*Pde6b*^*rd10/*+^ and NOG-*Pde6b*^*rd10/rd10*^ mice (E) were conducted at the age of 10 months. No ERG responses were detected with 2.0 log cd/m^2^/s flash light in NOG-*Pde6b*^*rd1*-*2J/rd1*-*2J*^ and NOG-*Pde6b*^*rd10/rd10*^ mice. Immunohistochemical analyses of 12-week-old mice are shown in (F) and (G). In NOG-*Pde6b*^*rd1*-*2J/rd1*-*2J*^ and NOG-*Pde6b*^*rd10/rd10*^ mice, both RHO (rhodopsin) and OPN1MW/OPN1SW (cone opsins) were absent. Cone opsins were labeled with a mixture of anti-M/L and S opsin antibodies.INL, inner nuclear layer; ONL, outer nuclear layer; GCL, ganglion cell layer. Scale bars, 200 μm (B and C) and 50 μm (F and G).

Optical coherence tomography (OCT) examination revealed normal ONL thickness in NOG-*Pde6b*^*rd/*+^ mice but loss of ONL in NOG-*Pde6b*^*rd/rd*^ littermates at postnatal week 8 ([Figures 1](#fig1){ref-type="fig"}B and 1C). Electroretinograms (ERGs) showed detectable a and b waves in NOG-*Pde6b*^*rd/*+^ mice; however, no ERG responses to 2.0 log cd/m^2^/s stimulus were recorded in NOG-*Pde6b*^*rd/rd*^ littermates ([Figures 1](#fig1){ref-type="fig"}D and 1E). At postnatal week 12, immunohistochemical analysis showed indistinguishable ONL thickness between NOG*-Pde6b*^+*/*+^ and NOG*-Pde6b*^*rd1*-*2J/*+^, or NOG-*Pde6b*^+*/*+^ and NOG-*Pde6b*^*rd10/*+^ littermates, whereas the ONL was substantially thinner in NOG-*Pde6b*^*rd1*-*2J/rd1*-*2J*^ and NOG-*Pde6b*^*rd10/rd10*^ mice with no immunoreactivity to rhodopsin (RHO) or cone opsins (OPN1MW and OPN1SW) ([Figures 1](#fig1){ref-type="fig"}F and 1G). These results indicate that photoreceptor degeneration occurred in both of our newly generated mouse models. We also checked the spleen cells in these four mouse lines ([Figure S1](#mmc1){ref-type="supplementary-material"}). CD4^+^ cells (helper T cells), CD8^+^ cells (cytotoxic T cells), CD19^+^ cells (B cells), and NKp46^+^ cells (NK cells) showed markedly lower ratios in spleen cells from both NOG-*rd1-2J* mice and NOG-*rd10* mice compared with their counterparts from *rd1-2J* mice and *rd10* mice, confirming the immunodeficient state (e.g., lack of T cells, B cells, and NK cells) of these NOG-rd mice. Interestingly, we also found enlarged populations of CD11b^+^ cells (including monocytes, macrophages, and microglia) in the spleens of both NOG mice, whereas the spleen cells of both *rd1-2J* and *rd10* mice had reduced populations of these CD11b^+^ cells ([Figure S1](#mmc1){ref-type="supplementary-material"}).

Earlier Degeneration Onset Observed in *rd10* Mice with NOG Background but Not in *rd1-2J* with NOG Background {#sec2.2}
--------------------------------------------------------------------------------------------------------------

We performed immunohistochemical analyses to compare degeneration time courses between *rd1-2J* and NOG-*rd1-2J* mice ([Figure 2](#fig2){ref-type="fig"}A), or *rd10* and NOG-*rd10* mice ([Figure 2](#fig2){ref-type="fig"}B). We evaluated the time courses of ONL loss using hierarchical Bayesian modeling ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C; see also [Experimental Procedures](#sec4){ref-type="sec"} and [Data S1](#mmc1){ref-type="supplementary-material"}). The ONL thickness was not significantly different between *rd1-2J* and NOG-*rd1-2J* at P7, P14, and P21, with distributions of estimated ONL thickness nearly overlapping ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}B; [Table S2](#mmc1){ref-type="supplementary-material"}). Many Iba-1 (AIF1)-positive microglia infiltrated at P14 but mostly disappeared at P21 along with photoreceptor loss ([Figure 2](#fig2){ref-type="fig"}C), consistent with a previous report ([@bib47]). In contrast, the ONL of NOG-*rd10* mice was thinner than that of *rd10* mice at P16, P23, and P30, implying earlier degeneration in the NOG background with concomitant microglia infiltration ([Figures 2](#fig2){ref-type="fig"}B and 2C). The timing of photoreceptor apoptosis was next assessed in *rd10*; only a few TUNEL-positive apoptotic cells were found in the ONL, with microglia limited to the inner and outer plexiform layers (IPL/OPL) at P16 in *rd10* mice and P12 in NOG-*rd10* mice, followed by the dramatic increase of TUNEL-positive cells in the ONL at P18 in *rd10* mice and P14 in NOG-*rd10* mice ([Figure S3](#mmc1){ref-type="supplementary-material"}A). The ONL thickness was reduced to less than half at P21 in *rd10* mice and at P16 in NOG-*rd10* mice ([Figure S3](#mmc1){ref-type="supplementary-material"}A). This observation was consistent with the estimation that the half-life period of the ONL degeneration is shorter in NOG-*rd10* mice than in *rd10* mice (95% credible interval for the half-life period was 2.61--5.87 days; mean 4.28 days) ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}C; [Table S2](#mmc1){ref-type="supplementary-material"}). Microglia were immunoreactive for CD68, a lysosome-associated membrane protein, suggesting their pro-inflammatory nature ([Figure 2](#fig2){ref-type="fig"}D).Figure 2Degeneration Time Course in rd Mice and NOG-rd Mice(A and B) Changes in ONL thickness and microglia infiltration in *rd1-2J* (A) and *rd10* (B) paired with their NOG counterparts, respectively, with AIF1 immunostaining (Iba-1 microglia marker, green).(C) The retinal degeneration time courses were indicated by the ONL thickness in all four mouse lines (n = 2--5 for each time point in each line). *Rd1-2J* and *rd10* were marked as red dots, with their NOG counterparts in blue. Lines and shaded areas, respectively, denote the median and the 95% credible interval of the estimated distribution of the thickness. Note that the estimated distributions of both *rd1-2J* strains are mostly overlapped, while the NOG-*rd10* mice showed earlier degeneration than *rd10* mice (n = 2--5). These analysis details are available in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}, [Figure S2](#mmc1){ref-type="supplementary-material"}, and [Data S1](#mmc1){ref-type="supplementary-material"}. Numbers of microglia found in the ONL at different time points indicates NOG-*rd10* mice tended to exhibit earlier microglia infiltration into the ONL than *rd10* mice.(D) Pro-inflammatory characteristic of infiltrating microglia (AIF1, green) in *rd10* and NOG-*rd10* mouse retinas was shown by staining against CD68 (active microglia marker, red).INL, inner nuclear layer; ONL, outer nuclear layer; these layers are also indicated by the side bars. Scale bars, 30 μm.

Since retinal degeneration is reported to be delayed in dark-reared *rd10* mice ([@bib4]), retinal degeneration may have been accelerated by light in *rd10* with NOG background, as the NOG strain is albino and possibly more susceptible to light. Indeed, animals raised in the dark from day 17 of pregnancy showed delayed degeneration in both NOG-*rd10* and *rd10*, although the NOG strain still degenerated faster than the non-NOG strain ([Figure S3](#mmc1){ref-type="supplementary-material"}B).

Absence of Immune Cells in Both NOG-rd and rd Mouse Retinas {#sec2.3}
-----------------------------------------------------------

We next studied the influence of the immune system upon retinal degeneration. Cytotoxic T cells, B cells, NK cells, and neutrophils in the retina were stained with anti-mouse CD8, CD19, NKp46 (NCR1), and LY6G antibodies, respectively ([Figure S3](#mmc1){ref-type="supplementary-material"}C). The staining revealed no invasion by the aforementioned immune cells in the retina from any of these mouse lines at around the peak of retinal degeneration or inflammation (*rd1-2J* mice and NOG-*rd1-2J* mice on P14, *rd10* mice on P23, and NOG-*rd10* mice on P16).

In NOG-*rd10*, the expression of glial fibrillary acidic protein increased earlier than that of *rd10*, indicating the activated status of Müller cells during photoreceptor degeneration, and the expression pattern was similar between *rd1-2J* and NOG-*rd1-2J* ([Figure S3](#mmc1){ref-type="supplementary-material"}D).

Differentiation and Characterization of Human ESC-Derived Retina {#sec2.4}
----------------------------------------------------------------

Retinal sheets for transplantation were prepared from hESCs (Crx::venus line), which were consistently differentiated into Crx::venus-positive retinas with a characteristic continuous neural epithelium formed by differentiation day 60 (DD60) ([Figures 3](#fig3){ref-type="fig"}A and 3B). These hESC retina had a layer of retinal progenitor cells positive for both PAX6 and Chx10 (VSX2) on the apical side with more differentiated PAX6-positive/Chx10-negative cells on the basal side ([Figure 3](#fig3){ref-type="fig"}C). Crx::venus-positive photoreceptor progenitor cells were observed on the apical margins, with some positive for the early photoreceptor marker Recoverin (RCVRN) and cone marker RxRγ (RARG) ([Figures 3](#fig3){ref-type="fig"}D and 3E). The presence of early-born cells including retinal ganglion cells (RGCs), amacrine cells, and horizontal cells are also suggested by the Brn3 (POU4F1), Islet1 (ISL1), calretinin (CALB2), and calbindin (CALB1) immunoreactivities ([Figures 3](#fig3){ref-type="fig"}F--3H).Figure 3Expression of Early Retinal Markers in Crx::Venus Human ESC-Derived Retina before Transplantation(A and B) hESC retinas were consistently differentiated into Crx::venus-positive optic vesicle-like tissues at DD60 (A) with characteristic continuous neural epithelium indicated by arrows (B).(C) Retinal progenitor cells positive for VSX2 (Chx10, red) and PAX6 (gray) are present on the apical side, while differentiated cells (PAX6^+^/VSX2^−^) are observed on the basal side.(D and E) Crx::venus-positive cells are present on the apical side at DD60, with some of them co-labeled with (D) early photoreceptor marker RCVRN (Recoverin, red) and (E) early cone marker RARG (RxRγ, red).(F) Presence of differentiated retinal ganglion cells and other inner cells on the basal side implied by ISL1 (Islet1, red) and POU4F1 (Brn3, gray) immunoreactivities.(G) CALB2 (calretinin, red)-positive staining suggests the presence of amacrine, subtypes of ganglion, and horizontal cells.(H) CALB1 (calbindin, red)-positive staining indicates the presence of horizontal cells and subtypes of ganglion cells.AP, apical side; BA, basal side. Scale bars, 200 μm (A and B) and 50 μm (C--H).

Long-Term Survival and Maturation of Transplanted Human ESC-Derived Retina in NOG-*rd1-2J* Mice {#sec2.5}
-----------------------------------------------------------------------------------------------

Crx::venus hESC retinal sheets were transplanted at DD64--DD66 into the subretinal space of 8-week-old NOG-*rd1-2J* mouse eyes, which were collected for immunohistology at DD200--DD220, as we previously observed that hESC retina requires approximately 200 days to mature ([@bib39]). Human nuclei (HuNu)-positive hESC retina presented ONL with mature cones and rods as presented previously by us and others ([@bib17], [@bib39]); Crx::venus- and rhodopsin-positive photoreceptors were in the organized rosette structures, wherein M/L and S cone opsins were usually present in larger Crx::venus-positive cells compared with rod photoreceptors, and localized at the inner and outer segment (IS/OS)-like structures ([Figures 4](#fig4){ref-type="fig"}A--4D). These IS/OS-like structures were also positive for peripherin-2 (PRPH2), a cell surface glycoprotein expressed in the OS ([Figure 4](#fig4){ref-type="fig"}E). We further characterized the ultrastructure of graft photoreceptor cells by electron microscopy and found components of mature photoreceptors such as mitochondria-rich IS, connecting cilia, and OS disc structures that were often sectioned obliquely ([Figures 4](#fig4){ref-type="fig"}F and 4G).Figure 4Expression of Maturation and Synapse Markers by Transplanted Crx::Venus hESC-Derived Retina in NOG-*rd1-2J* Mice(A and B) Subretinal graft cells in the host NOG-*rd1-2J* mouse were positive for HuNu (human nuclei, red) staining, wherein the (A) Crx::venus (green)- or (B) rhodopsin-positive photoreceptors (red) formed organized rosette structures.(C and D) M/L and S cone opsins were usually present in larger Crx::venus-positive cells (red arrows) compared with rod photoreceptors and sometimes localized in IS/OS-like structures (yellow arrows).(E) Rod photoreceptor IS/OS formation was suggested by expression of PRPH2 (peripherin-2, red) inside the rosette-like structure (arrows).(F and G) Graft cells in rosette-like structure show components of mature photoreceptors by electron microscopy. (F′) Higher magnification of solid line boxed area in (F) shows mitochondria-rich IS, connecting cilia (cc) and disrupted disc structures (yellow arrow); (F″) higher magnification of dotted line boxed area in (F) shows many fragments of disc structures inside the rosette on an oblique section (orange arrows). (G) Continuous view of connecting cilia and OS from a cell body in another section of the same rosette.(H) 3D confocal image of transplanted area stained against CTBP2 (RIBEYE as presynaptic marker, arrowheads) and PRKCA (PKCα as rod bipolar cell marker, gray). CTBP2 was co-localized at the contact site of graft photoreceptors (green) and host bipolar cells that can be traced back into the host retina (yellow and orange arrows). (H′ and H″) The views indicated by arrows are the representative contact sites, and magnified views are presented as projected optical section and orthogonal views between the indicated lines.INL, inner nuclear layer; IS, inner segment; OS, outer segment. DD200--DD220 (A--D). Scale bars, 50 μm (A and B), 20 μm (C--E), 5 μm (F), 1 μm (F′--G), and 10 μm (H--H″).

Other inner retinal cells were also present in transplants, as suggested by the immunoreactivities against PKCα (PRKCA, expressed exclusively in rod bipolar cells) and calretinin (expressed in amacrine and ganglion cells) ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Microglial cells of non-active ramified morphology were observed in the host retina and the graft, where they were often present inside the rosette of graft photoreceptors ([Figures S4](#mmc1){ref-type="supplementary-material"}C and S4C′). Electron microscopy showed that these microglia were surrounded by oblique sections of OS disc-like structures, and some fractions of OS disc-like structures were engulfed by the microglia ([Figures S4](#mmc1){ref-type="supplementary-material"}E--S4E″).

At the host-graft interface, host bipolar cells were observed extending dendrites to Crx::venus-positive graft photoreceptors and the expression of RIBEYE, the synaptic ribbon-specific protein stained against CTBP2, was observed at the contact sites ([Figure 4](#fig4){ref-type="fig"}H and higher-magnification images in [Figures 4](#fig4){ref-type="fig"}H′ and 4H″). Müller glia in the host retina did not seem to block graft cell integration ([Figure S4](#mmc1){ref-type="supplementary-material"}D).

Graft-Driven Light Responses Recorded in Host Retinal Neurons {#sec2.6}
-------------------------------------------------------------

Although *rd1* mice exhibit severe retinal degeneration with rod loss, cone cells can remain for weeks after rods have completely degenerated. We tested whether NOG-*rd1-2J* mouse retinas could elicit light responses at the time of transplantation (postnatal week 8). These retinas showed patchy, monolayered ONL and cone arrestin (ARR3) immunoreactivity in the distal retina but barely in the proximal area, with a similar trend observed in 12-week-old NOG-*rd1-2J* ([Figure S5](#mmc1){ref-type="supplementary-material"}) retinas. We barely detected light responses from 8-week-old retinas (n = 4) but recorded a few responses in some 12-week-old retinas (n = 4, [Figure S5](#mmc1){ref-type="supplementary-material"}D), again indicating the variability in the degree of cone degeneration. However, these responses were constrained to the distal retina, and no reaction was observed in the proximal area, defined as the area within 1-mm distance from the optic nerve disc.

Light-responsive RGCs of transplanted retinas were counted objectively and stringently, by only counting light responses observed as the same responsive pattern at least twice in the three repetitive recordings. Responses were further classified into either "normal responses" (transient-, brisk-sustained-, or sustained-ON; transient OFF; ON-OFF or sustained ON-OFF; ON suppression) or "hypersensitive" (ON-hyperactive; OFF-hyperactive; delayed-hyperactive) responses as previously described ([@bib26]). We previously reported that mouse iPSC (miPSC) retinal tissue can elicit light responses in host mouse RGCs ([@bib26]). In the present study, eight retinas were tested for light responses to full-field light stimuli at 12.84 log photons/cm^2^/s (0.45 log cd/m^2^/s, the same condition as in our previous report) by multi-electrode array (MEA) recording at 20--27 weeks after transplantation (DD200--DD260). While some samples showed none (3 of 8 retinas) or only weak or ambiguous light responses (2 of 8 retinas), evident light responses were recorded from three transplanted retinas in the proximal area ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}).Figure 5Classic Photoreceptor Responses Elicited in NOG-*rd1-2J* Mouse after Transplantation of hESC-Derived Retina(A) *In vivo* imaging of a transplanted eye at postoperative day 112 (DD176). Fluorescent angiography shows the Crx::venus-positive graft under the retinal vessels. No sign of rejection was observed.(B) Isolated retina from (A) with Crx::venus hESC-derived graft (DD204) mounted on the MEA probe with RGC on the electrodes side.(C) Averaged peri-stimulus time histogram of RGC spikes (after spike sorting) against three repeated mesopic light stimuli (12.84 log photons/cm^2^/s) after washout of L-AP4. Yellow bars indicate the 1-s light stimulation. Red and blue arrows indicate the channels with the RGCs showing normal and hypersensitive responses, respectively. The proximal retina (\<1 mm from disc) is indicated in pink, and the area covered by the graft is shown in light green.(D) Spatial distribution of the RGC numbers (spike sources) shown as normal (red bars) or hypersensitive (blue bars) in accordance with the 64 electrodes, ranging from 1 to 2 cells per channel. Electrodes covered by the graft are shown in yellow.(E) Histogram of total RGC cluster numbers in electrodes covering grafted (on graft) or non-grafted (off graft) areas. RGC with normal responses (red) in grafted areas increased along with stimulus intensity and were abolished in the presence of L-AP4. Hypersensitive responses (blue) in non-grafted areas were insensitive to L-AP4. Stimulus intensities are shown in log photons/cm^2^/s.(F) Overview of the retinal sheet after MEA recording shown in (B). Transplanted grafts were distributed in the subretinal area (orange arrowheads).(G) Magnified view of a light-responsive area (yellow box in F, around channel 12 in C). Yellow arrowheads mark the potential synaptic connections between host rod bipolar cells (PKCα-positive) and graft Crx::venus-positive photoreceptor cells expressing synaptic ribbon proteins (CTBP2-positive).Scale bars, 150 μm (F) and 20 μm (G).Figure 6Light Responses in the Proximal Retinas of hESC-Retina Transplanted NOG-*rd1-2J* MiceExamples of the other two transplanted retinas with light-driven RGC responses detected by MEA recording. Light responses are marked by arrows in red for normal and blue for hypersensitive responses. Red dotted boxes indicate the electrode areas. The proximal retina (within 1 mm from disc) is indicated in pink shadow, and the area covered by graft in green shadow.(A) A sample with evident light responses. The response was evident only after L-AP4 washout against mesopic light stimuli (12.84 log photons/cm^2^/s).(B) Another sample with RGCs with light responses before and after 9-*cis*-retinal and L-AP4 treatment with mesopic light stimuli.Scale bars, 150 μm.

MEA recording of one responding retina is presented in [Figure 5](#fig5){ref-type="fig"} along with its corresponding *in vivo* images. At DD176, typical Crx::venus-positive rosette formation with no inflammatory signs, such as increased vascular permeability or leakage of fluorescein dye at the graft site, was confirmed by angiography ([Figure 5](#fig5){ref-type="fig"}A). The same retina was recorded by the MEA system at DD204, and the representative peri-stimulus time histogram (PSTH) demonstrates the RGC spikes in each recording channels after recovery from the ON pathway blocker (L-AP4; 20 μM) application ([Figures 5](#fig5){ref-type="fig"}B and 5C). Overall, 11 RGCs were recorded with "normal" responses (4 transient ON; 2 sustained ON-OFF; 2 brisk-sustained ON; 3 sustained ON) and 13 RGCs with hypersensitive response (13 ON-hypersensitive) after 9-*cis*-retinal replenishment. In the presence of L-AP4, only 11 RGCs with hypersensitive responses were detected (9 ON-hyperactive; 2 delayed-hyperactive). After washout, normal responses were again detected in nine RGCs (4 transient ON; 2 brisk-sustained ON; 3 sustained ON) while 11 RGCs showed hypersensitive responses (9 ON-hyperactive; 2 delayed-hyperactive) ([Figure 5](#fig5){ref-type="fig"}D). The "normal responses" as clustered by our program resembled those of wild-type RGCs in response to L-AP4, and increased along with stimulus intensity changes, whereas some hypersensitive responses did not change with or without L-AP4 ([Figure 5](#fig5){ref-type="fig"}E). The subsequent whole-mount immunostaining strongly suggests the host RGC origin of "normal" light responses over the mature graft area, where host bipolar cell contacts with the graft photoreceptors are indicated by RIBEYE staining ([Figures 5](#fig5){ref-type="fig"}F and 5G).

Two other samples that showed light-responsive RGC activities indicative of graft origin are presented in [Figure 6](#fig6){ref-type="fig"}. One sample showed clear light responses only after L-AP4 washout over the graft area ([Figure 6](#fig6){ref-type="fig"}A). The other sample showed RGC responses even before 9-*cis*-retinal treatment, and the number of light-responsive RGCs decreased upon L-AP4 treatment but increased again after washout, although classified as hypersensitive patterns (6 ON-hyperactive) ([Figure 6](#fig6){ref-type="fig"}B).

In two other samples, the number of light-responsive RGCs was so few on the graft that we could not conclusively determine the origin of the responses. In the rest of the three samples only a small fraction of the graft was laid on the electrodes, and no RGC responses were detected.

To test whether NOG-*rd1-2J* mice are as adequate and competent to accept retina transplants as *rd1-2J* mice in our previous study, we also transplanted miPSC retina (Nrl-GFP/ROSA:Nrl-CtBP2-tdTomato iPSC line) ([@bib26]) at the same age as the hESC retina recipient NOG-*rd1-2J* mice. After 5 weeks of transplantation, evident microERG (mERG) responses were consistently recorded over the graft area in all the transplanted samples as well as typical RGC light responses sensitive to L-AP4 (n = 4) ([Figure 7](#fig7){ref-type="fig"}).Figure 7mERG and RGC Responses Elicited in NOG-*rd1-2J* Mice after miPSC-Retina Transplantation(A) mERG recordings and representative peri-stimulus time histogram after L-AP4 washout and spike sorting are presented along with images of miPSC retina transplants mounted on the MEA probe (60MEA200/30iR-Ti-gr, n = 4). Electrodes with light-responsive RGCs are indicated by arrows. Recording areas are indicated by red dotted line boxes. The proximal retinas (within 1 mm from disc) are indicated in pink, with the areas covered by the grafts in green.(B) Representative mERG in the red- and green-boxed channels in (A). L-AP4 abolished the negative wave (RGC response, red box) or the positive wave (ON bipolar response, green box).(C) L-AP4-sensitive ON suppression (blue) and sustained-ON responses (purple) are shown as representative RGC responses in the channels pointed out by blue and purple arrows in (A).

Discussion {#sec3}
==========

In this study, we established two immunodeficient retinal degeneration model mouse strains, NOG-*rd1-2J* and NOG-*rd10*, for transplantation of human retinal cells or tissue. Initially, our goal was to obtain two model lines with different degeneration speeds. However, degeneration was unexpectedly fast in NOG-*rd10* mice in comparison with *rd10* mice. In these NOG backgrounds, immune cells such as T cells, B cells, and NK cells were markedly reduced, whereas microglia were similarly present compared with non-NOG mice. We did not observe infiltration of these T, B, or NK cells in the retina during the photoreceptor degeneration in either *rd1-2J* or *rd10* mice, even though these mouse lines both possess an intact immune system. There are controversial reports about the role of microglia in retinal degeneration ([@bib1], [@bib16], [@bib32]). We observed microglia infiltration into ONL after the detection of initial apoptosis marker appearance in photoreceptor cells, both in NOG-*rd10* and *rd10* mice. Although some reported that T cells could influence microglia to be neurotoxic or neurotrophic ([@bib11]), the lack of T cell infiltration argues against this mechanism. The pro-inflammatory phenotype of microglia indicated by CD68 staining was similarly observed in both *rd10* and NOG-*rd10* mice. It was reported that different inbred strains showed markedly different sensitivities to light ([@bib23]). Since retinas from dark-reared *rd10* mice exhibited delayed degeneration onset while dark rearing had no effect on *rd1-2J* retinal degeneration ([@bib4]), sensitivity to light may affect the pathology of *rd10* mice. In our study, since degeneration in both *rd10* and NOG-*rd10* mice was slowed down when dark-reared, in addition to light effect, the immunodeficiency or other genetic differences between the different strain backgrounds may have also accelerated the degeneration.

We experienced difficulties in observing maturation of hESC retinas in *rd1* mice even with immunosuppression, but with NOG-*rd1-2J* mice the transplanted hESC retinas consistently developed mature ONL with rod and cone opsins. Furthermore, graft photoreceptors show signs of developing IS/OS structures as evidenced by electron microscopy. However, we had not yet shown any function by hESC/iPSC retina following transplantation. In the present study, light-responsive RGC activities were detected in 3 of 8 retinas over the grafts by MEA recording from 28-week-old or older NOG-*rd1-2J* mice (20 weeks or more after transplantation). At such advanced stage of retinal degeneration or even younger NOG-*rd1-2J*, no remaining cone activity was observed in the proximal retina where the grafts usually lay. Although we could not completely deny the rescue effect on the host's remaining cones by grafts, some of the light responses recorded after transplantation were clearly distinguished by their proximity to the disc and location directly over the graft. These responses were not sparsely covering only a few electrodes as in the non-transplanted retina but were detected in clusters covering multiple electrodes directly in the grafted area, suggesting that they are more likely driven by the graft photoreceptors rather than remaining cones.

Hypersensitive response patterns were initially observed in the degenerating retinas, preferentially to a bright light stimulus but barely with our regular light stimuli at 0.45 log cd/m^2^/s ([@bib26]). After transplantation, however, many RGCs, usually located in and around the grafted area, were classified as "light-responsive hypersensitive" even to the regular light stimuli. Some of the hypersensitive responses were rather ambiguous as they cannot be clearly distinguished from the normal patterns, such as whether to be sustained ON or ON-hyperactive. We propose that these patterns represent either degenerating or regenerating processes and may possibly originate from the immature host-graft synaptic connections or cells associated with the circuitry formation. No OFF responses were detected upon L-AP4 block, suggesting that the OFF pathway may not yet have been recovered. The L-AP4-insensitive hypersensitive activities may be partly derived from intrinsically photosensitive RGCs, despite the use of Opsinamide. Alternatively, these responses may suggest a wrongly or immaturely rewired circuitry tethered to the rather excitable RGCs in degenerating retina ([@bib8]). It is noteworthy that we obtained light responses in one sample even before the 9-*cis*-retinal treatment ([Figure 6](#fig6){ref-type="fig"}B), which indicates that graft photoreceptors were readily functional with functional visual pigments *in vivo*, even though the rosette formation dampens normal contact with RPE cells.

In the present study, we did not detect full-field ERG response after transplantation. Since detectable ERG response is estimated to require more than 150,000-cell integration ([@bib30]), our host-graft integration is not considered to be sufficient. However, considering that a patient with non-recordable full-field ERG still has a limited visual field, the absence of *in vivo* full-field ERG does not indicate total blindness. For the *ex vivo* recording, although the evident mERGs were elicited in miPSC retina grafts at 5 weeks after transplantation, we did not detect mERG in hESC retina grafts to the same 10-ms flashlight (1/100 photons compared with the multiunit recordings of RGC). Since the mERG responses in miPSC were mostly abolished by L-AP4, the wave components likely represented the postsynaptic bipolar cells and RGCs of either graft or host rather than the properly oriented photoreceptors of limited amount inside the graft rossettes ([@bib9]). The lack of mERG wave components but not RGC multiunit responses in hESC retina suggests that the graft photoreceptors did not convey a strong enough response to the weaker stimulus. Still, we obtained RGC responses in 3 of 7 retinas with a substantial hESC transplant, which suggests the presence of functional hESC retinal photoreceptors, although RGC responses were detected in all samples from miPSC retina-transplanted NOG-*rd1-2J* mice. The lower responsiveness of hESC retina compared with miPSC retina in NOG-*rd1-2J* mice may be attributed to (1) fewer functional photoreceptors in hESC retina than in miPSC retina, (2) the advanced and aged host environment at the time of synaptic integration of hESC retinas, since hESC retina takes a longer time to reach synaptogenesis stage than does miPSC retina, and (3) inefficient synaptic formation in xenotransplantation compared with allotransplantation as suggested by [@bib24]. However, this incompatibility of hESC/iPSC retina would not be an issue in human host retinas. Finally, (4) the Crx::venus ESC graft we have used here may have negatively affected synaptogenesis, since functional maturation is reportedly delayed in Crx^+/−^ mice ([@bib10]).

In summary, by introducing immune-deficient end-stage rd mouse models, we were able to integrate hESC retinal sheets in the transplanted retinas for an extended period. These grafts showed signs of photoreceptor maturation including light-responsive IS/OS formation and synaptogenesis, and tentative functional integration with host retina, albeit to an extent less than with allotransplantation. This study supports the use of these animals in preclinical studies, as well as the competency of hESC retina for future clinical applications in RP patients.

Experimental Procedures {#sec4}
=======================

All animal experiments were conducted in accordance with local guidelines and the ARVO statement on the use of animals in ophthalmic and vision research. All experimental protocols were approved by the committee of the RIKEN Center for Developmental Biology.

Development of NOG-*rd1-2J* and NOG-*rd10* Mice {#sec4.1}
-----------------------------------------------

To establish two types of NOG-rd transgenic mice, we used marker-assisted screening methods ([Figure 1](#fig1){ref-type="fig"}A). Details are described, with genotyping information, in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

hESC-Derived Retina Differentiation and Subretinal Transplantation {#sec4.2}
------------------------------------------------------------------

Human ESCs (KhES-1 line) were cultured in accordance with the hESC research guidelines of the Japanese government. The hESC reporter line (Crx::venus) was maintained and differentiated as previously described with a slight modification ([@bib20], [@bib28], [@bib39]). Human ESC retinal sheets were transplanted at DD64--DD66 as described previously ([@bib2], [@bib39]). Details are provided in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Details for animal sources and methods for *in vivo* electroretinogram and ocular imaging, electron microscopy, miPSC retina transplantation, and immunohistochemistry with antibody information are included in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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